Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help?
OBJECTIVE
Persistent urinary urgency and frequency, and chronic urethral and/or pelvic pain in women are often a diagnostic and therapeutic challenge. This can be frustrating for patients and physicians. The search for an infectious agent often proves futile and after multiple ineffective treatment regimens patients may be classified as having interstitial cystitis or referred to a psychiatrist as the last option. We evaluated whether treatment with doxycycline of the patient and her sexual partner would be beneficial.


METHODS
Women presenting with a history of urinary urgency and frequency, and chronic urethral and/or pelvic pain often associated with dyspareunia and/or a history of recurrent urinary tract infection were evaluated. Initial examinations included urethral and cervical/vaginal swabs, serum analysis, urine examination and culture, and bladder barbitage. A total of 103 women with a median age of 46 years (range 21 to 84) and with a median symptoms history of 60 months (range 3 to 480) were included. All patients had trigonal leukoplakia at cystoscopy, in 15% an infectious organism was identified and 30% had leukocyturia. All were treated with doxycyclines, and a vaginal antimicrobic and/or antimycotic agent following the same regimen, including treatment of the sexual partner.


RESULTS
After treatment with doxycycline 71% of the women were symptom-free or had a subjective decrease in symptoms.


CONCLUSIONS
Treatment with doxycycline is effective in more than two-thirds of patients complaining of persistent frequency and urgency, chronic urethral and/or pelvic pain, and dyspareunia as well as a history of recurrent urinary tract infections. In women with negative urinary cultures but a history of urgency/frequency probative treatment with doxycycline is justified and endoscopic findings may support the hypothesis of chronic infection. This should be done especially before contemplating psychiatric treatment or diagnosing the patient with interstitial cystitis. We attribute this high success rate to simultaneous treatment of the sexual partner, who may be an asymptomatic carrier, although this remains to be proved.
Burkhard
Fiona C
FC
Department of Urology, University of Berne, Berne, Switzerland. fiona.burkhard@insel.ch
Blick
Nadja
N
Hochreiter
Werner W
WW
Studer
Urs E
UE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018856:Cystitis, Interstitial / Q000175:diagnosis; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007971:Leukoplakia / Q000175:diagnosis; D008875:Middle Aged; D017699:Pelvic Pain / Q000188:drug therapy / Q000382:microbiology; D014522:Urethral Diseases / Q000188:drug therapy / Q000382:microbiology; D014555:Urination Disorders / Q000188:drug therapy* / Q000382:microbiology; D014625:Vaginal Neoplasms / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D004318:Doxycycline